 Coordinator

T. Helbich,

Vienna/AT

 Moderator

S. Vinnicombe,

Cheltenham / UK

 Registration information

All ESOR 2023 Foundation Courses are included in the ESR Premium Education Package 2023, which provides access to numerous educational services such as Education on Demand, Eurorad, and content on ESR Connect.

For more details, please visit the ESR Premium Education Package Area

 CME accreditation
ONLY for Live Streaming

The course has been granted
5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.

Certificates with CME credits will be issued only after watching the live stream and completing an online evaluation form.

No CME credits will be available for watching on demand.

ESOR Foundation Course

BREAST IMAGING | Online | April 26, 2023 | 12:30 – 18:30 CEST

Course information

This course is aimed at residents in their 4^th and 5^th year of training in radiology and recently board- certified radiologists interested in Breast Imaging. It is adhered to Level II of the European Training Curriculum and is intended to provide an in-depth view into modern state-of the-art imaging in breast diseases. The course includes six topics consisting of 40 minutes of theory and case presentations followed by a live Q&A section after each session for interaction with the faculty members.

Learning objectives

to appreciate the need of structured reporting to understand how to communicate breast imaging findings to patients
to learn about the importance to move breast screening in another level
to appreciate new developments in mammography, US, and MRI in the screening and diagnostic setting
to get an update about the important role of image guided interventions

Programme Online

Wednesday, April 26, 2023

12:30–13:10	Structured reporting with BIRADS A. Athanasiou, Athens/GR – To be familiar with the BI-RADS Lexicon descriptors and classification categories of breast lesions in all modalities (Mammography MG, Ultrasound US and Magnetic Resonance Imaging MRI). – To understand the positive predictive values attributed to each classification category and its importance for the management of breast lesions. – To be able to write a structured report based on the aforementioned recommendations
13:10-13:30	Patient communication: a patient perspective C. Justich, Vienna/AT
13:30-14:10	Breast cancer screening: the need to become personalised S. Vinnicombe, Cheltenham/UK – To recognise the strengths and weaknesses of conventional mammographic screening – To understand the clinical scenarios where enhanced screening may be required – To appreciate the pro’s and con’s of supplemental or alternative imaging modalities
14:10–14:50	Update on 2D and 3D mammography T. Helbich, Vienna/AT – To report on the drawbacks of conventional mammography – To understand technical details behind 2D and 3D digital based mammography techniques – To report on the results of 2D and 3D digital based mammography techniques such as tomosyntheses and contrast enhanced mammography
14:50–15:15	Q&A
15:15–15:50	Break
15:50–16:30	Ultrasound of the breast: morphology and more A. Athanasiou, Athens/GR – To understand how to improve image quality on ultrasonography on B-mode and on Color Doppler. – To be familiar with advanced ultrasonographic techniques (elastography, 3D, SMI, Angio-Plus, contrast-enhanced ultrasound). – To review the indications of percutaneous interventional procedures under ultrasonographic guidance
16:30–17:10	MRI of the breast: an update S. Vinnicombe, Cheltenham/UK -To recognize accepted and evolving indications for breast MRI -To appreciate the advances in breast MRI sequences and protocols including abbreviated MRI -To review structured MRI reporting with BI-RADS
17:10-17:50	Image-guided interventions Helbich, Vienna/AT – To understand the importance of intervention in the work-up of breast problems – To review various techniques and approaches – To learn how to interpretate and manage histopathologic results following breast interventions
17:50–18:30	Q&A